Drug Shortage Report for DEFEROXAMINE MESYLATE FOR INJECTION
Report ID | 105289 |
Drug Identification Number | 02241600 |
Brand name | DEFEROXAMINE MESYLATE FOR INJECTION |
Common or Proper name | Deferoxamine Mesylate for Injection |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | DEFEROXAMINE MESYLATE |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAPERITONEAL INTRAVENOUS SUBCUTANEOUS |
Packaging size | 10 x 500mg GVL |
ATC code | V03AC |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-02-05 |
Estimated end date | |
Actual end date | 2020-05-28 |
Shortage status | Resolved |
Updated date | 2020-05-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-05-29 | French | Compare |
v6 | 2020-05-29 | English | Compare |
v5 | 2020-04-08 | French | Compare |
v4 | 2020-04-08 | English | Compare |
v3 | 2020-02-06 | English | Compare |
v2 | 2020-02-05 | French | Compare |
v1 | 2020-02-05 | English | Compare |
Showing 1 to 7 of 7